Luisella Spiga

Luisella Spiga

Auto-generated profile, based on publicly available information

Luisella Spiga

Department of Microbiology, University of Texas Southwestern Medical Center, Dallas, USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 January 2018 in Nature
Verified
Journal Article
Closed access
PDF file
WZWenhan Zhu
Wenhan Zhu
MWMaria G. Winter
Maria G. Winter
MBMariana X. Byndloss
Mariana X. Byndloss
LSLuisella Spiga
Luisella Spiga
BDBreck Duerkop
Breck Duerkop
SWSebastian E. Winter
Sebastian E. Winter

1 February 2017 in Cell Host & Microbe
Verified
Journal Article
Closed access
EHElizabeth R. Hughes
Elizabeth R. Hughes
MWMaria G. Winter
Maria G. Winter
BDBreck Duerkop
Breck Duerkop
LSLuisella Spiga
Luisella Spiga
TCTatiane Furtado de Carvalho
Tatiane Furtado de Carvalho
SWSebastian E. Winter
Sebastian E. Winter

5 January 2017 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
FFFranziska Faber
Franziska Faber
PTParameth Thiennimitr
Parameth Thiennimitr
LSLuisella Spiga
Luisella Spiga
MBMariana X. Byndloss
Mariana X. Byndloss
YLYael Litvak
Yael Litvak
ABAndreas J. Bäumler
Andreas J. Bäumler
Intestinal inflammation caused by Salmonella enterica serovar Typhimurium increases the availability of electron acceptors that fuel a respiratory growth of the pathogen in the intestinal lumen. Here we show that one of the carbon sources driving this respiratory expansion in the mouse model is 1,2-propanediol, a microbial fermentation product. 1,2-propanediol utilization required intestinal inflammation induced by virulence factors of the pathogen. S. Typhimurium used both aerobic and anaerobic respiration to consume 1,2-propanediol and expand in the murine large intestine. 1,2-propanediol-utilization did not confer a benefit in germ-free mice, but the pdu genes conferred a fitness advantage upon S. Typhimurium in mice mono-associated with Bacteroides fragilis or Bacteroides thetaiotaomicron. Collectively, our data suggest that intestinal inflammation enables S. Typhimurium to sidestep nutritional competition by respiring a microbiota-derived fermentation product. Salmonella enterica serovar Typhimurium induces intestinal inflammation to induce the generation of host-derived respiratory electron acceptors, thereby driving a respiratory pathogen expansion, which aids infectious transmission by the fecal oral route. However, the identity of nutrients serving as electron donors to enable S. Typhimurium to edge out competing microbes in the competitive environment of the gut are just beginning to be worked out. Here we demonstrate that aerobic and anaerobic respiratory pathways cooperate to promote growth of Salmonella on the microbial fermentation product 1,2-propanediol. We propose that pathogen-induced intestinal inflammation enables Salmonella to sidestep nutritional competition with the largely anaerobic microbiota by respiring a microbe-derived metabolite that cannot be consumed by fermentation.

1 September 2017 in Cell Host & Microbe
Verified
Journal Article
Closed access
LSLuisella Spiga
Luisella Spiga
MWMaria G. Winter
Maria G. Winter
TCTatiane Furtado de Carvalho
Tatiane Furtado de Carvalho
WZWenhan Zhu
Wenhan Zhu
EHElizabeth R. Hughes
Elizabeth R. Hughes
SWSebastian E. Winter
Sebastian E. Winter

29 July 2019 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
WZWenhan Zhu
Wenhan Zhu
NMNaoteru Miyata
Naoteru Miyata
MWMaria G. Winter
Maria G. Winter
AAAlexandre Arenales
Alexandre Arenales
EHElizabeth R. Hughes
Elizabeth R. Hughes
SWSebastian E. Winter
Sebastian E. Winter
Chronic inflammation and gut microbiota dysbiosis, in particular the bloom of genotoxin-producing E. coli strains, are risk factors for the development of colorectal cancer. Here, we sought to determine whether precision editing of gut microbiota metabolism and composition could decrease the risk for tumor development in mouse models of colitis-associated colorectal cancer (CAC). Expansion of experimentally introduced E. coli strains in the azoxymethane/dextran sulfate sodium colitis model was driven by molybdoenzyme-dependent metabolic pathways. Oral administration of sodium tungstate inhibited E. coli molybdoenzymes and selectively decreased gut colonization with genotoxin-producing E. coli and other Enterobacteriaceae. Restricting the bloom of Enterobacteriaceae decreased intestinal inflammation and reduced the incidence of colonic tumors in two models of CAC, the azoxymethane/dextran sulfate sodium colitis model and azoxymethane-treated, Il10-deficient mice. We conclude that metabolic targeting of protumoral Enterobacteriaceae during chronic inflammation is a suitable strategy to prevent the development of malignancies arising from gut microbiota dysbiosis.

18 February 2020 in Cell Host & Microbe
Verified
Journal Article
Closed access
WZWenhan Zhu
Wenhan Zhu
MWMaria G. Winter
Maria G. Winter
LSLuisella Spiga
Luisella Spiga
EHElizabeth R. Hughes
Elizabeth R. Hughes
RCRachael Chanin
Rachael Chanin
SWSebastian E. Winter
Sebastian E. Winter